Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple Add-On drug make C-Section recovery smoother?

NCT ID NCT05991466

Symptom relief Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether adding dexmedetomidine to standard spinal anesthesia or a TAP block (a type of pain injection) improves recovery quality and pain relief for women having planned C-sections. 141 full-term pregnant women participated. The goal was to see if the drug leads to better recovery scores and longer time before needing additional pain medication.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dexmedetomidine (added to bupivacaine in spinal anesthesia or TAP block)
What this could lead to
If it works, this could lead to better recovery and longer pain relief after planned C-sections.
What could go wrong
This is a small, completed Phase 4 trial, so results may not apply to all women. The drug may cause side effects like sedation or low blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

141 people

The number who actually took part.

Started

Jan 2022

Finished

Dec 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants will be full-term pregnant females * ASA classification I or ll. * Aged between 18 and 40 years. * Singleton pregnancy Exclusion Criteria: * Refusal of block. * Bleeding disorders (platelets count \<150,000; INR\>1.5; PC\<60%). * wounds or infection at the puncture site. * Known allergy to local anesthetic drugs. * Contraindications to neuroaxial block. * Contraindications to TAP block..

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for The quality of recovery (obsqor-11) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

The quality of recovery (obsqor-11)

Contacts and locations

Locations

  • Faculty of Medicine, Cairo University

    Cairo, Cairo Governorate, 11562, Egypt